Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL2070809

N[C@@H](CCCCCC(=O)O)c1nnc(-c2ccc3ccccc3c2)o1.O=C(O)C(F)(F)F

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TBXAS1 P24557 1/20 0.40
S1PR4 O95977 5/20 0.39
S1PR5 Q9H228 5/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
HDAC1 Q13547 4/20 0.39
S1PR1 P21453 2/20 0.38
CYP1A2 P05177 2/20 0.37
ALDH1A1 P00352 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
HPGD P15428 1/20 0.37
TSHR P16473 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HSD17B10 Q99714 1/20 0.37
EPHX1 P07099 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
CCNC P24863 1/20 0.36
CDK8 P49336 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2070811 0.86 CA1 (0.37) TBXAS1CA1CA2HDAC1CYP1A2
SCHEMBL2072937 0.83 HDAC1 (0.48) CA1CA2HDAC1CYP1A2ALDH1A1
Trifluoroacetic Acid SCHEMBL2074779 0.79 HDAC1 (0.44) TBXAS1S1PR4S1PR5HDAC1S1PR1
Trifluoroacetic Acid SCHEMBL2070996 0.77 HDAC1 (0.62) HDAC1HDAC6
Trifluoroacetic Acid SCHEMBL2073246 0.77 HDAC1 (0.62) HDAC1HDAC6
Trifluoroacetic Acid SCHEMBL2074056 0.76 HDAC1 (0.60) S1PR4S1PR5HDAC1S1PR1HDAC6
SCHEMBL2071048 0.75 MAPT (0.52) HDAC1ALDH1A1HPGDTSHRSMN1; SMN2
SCHEMBL2073408 0.72 HDAC1 (0.48) TBXAS1S1PR4S1PR5HDAC1HDAC6
Trifluoroacetic Acid SCHEMBL2075049 0.71 HDAC1 (0.61) HDAC1HDAC6
Trifluoroacetic Acid SCHEMBL13730513 0.71 TACR1 (0.52) HDAC1ALDH1A1CYP3A4CYP2C9HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1828171-B1 HETEROCYCLE DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS ANGELETTI P IST RICHERCHE BIO (IT) 2014-03-12 EP disclosed
US-7863294-B2 Heterocycle derivatives as histone deacetylase (HDAC) inhibitors INSTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2011-01-04 US disclosed
US-20090048228-A1 Heterocycle Derivatives As Histone Deacetylase (Hdac) Inhibitors MSD ITALIA S.R.L. (IT) 2009-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090048228-A1 Heterocycle Derivatives As Histone Deacetylase (Hdac) Inhibitors HDAC1, HDAC5, HDAC11 TBXAS1 1197/4885S1PR4 4165/4885S1PR5 3632/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.